T Lymphocytes and Inflammatory Mediators in the Interplay Between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers

Overview

Journal J Immunol Res

Publisher Wiley

Specialty Allergy & Immunology

Date 2017 Mar 16

PMID 28293644

Citations 50

Authors

Anna Mietelska-Porowska

Urszula Wojda

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disorder and the main cause of dementia. The disease is among the leading medical concerns of the modern world, because only symptomatic therapies are available, and no reliable, easily accessible biomarkers exist for AD detection and monitoring. Therefore extensive research is conducted to elucidate the mechanisms of AD pathogenesis, which seems to be heterogeneous and multifactorial. Recently much attention has been given to the neuroinflammation and activation of glial cells in the AD brain. Reports also highlighted the proinflammatory role of T lymphocytes infiltrating the AD brain. However, in AD molecular and cellular alterations involving T cells and immune mediators occur not only in the brain, but also in the blood and the cerebrospinal fluid (CSF). Here we review alterations concerning T lymphocytes and related immune mediators in the AD brain, CSF, and blood and the mechanisms by which peripheral T cells cross the blood brain barrier and the blood-CSF barrier. This knowledge is relevant for better AD therapies and for identification of novel biomarkers for improved AD diagnostics in the blood and the CSF. The data will be reviewed with the special emphasis on possibilities for development of AD biomarkers.

Citing Articles

Identification of UBE2N as a biomarker of Alzheimer's disease by combining WGCNA with machine learning algorithms.

Feng G, Zhong M, Huang H, Zhao P, Zhang X, Wang T Sci Rep. 2025; 15(1):6479.

PMID: 39987324 PMC: 11847011. DOI: 10.1038/s41598-025-90578-z.

Immunological characterization of pleural effusions in pediatric patients.

Flogel L, Kaiser E, Hans M, Goedicke-Fritz S, Bous M, Abdul-Khaliq H Front Immunol. 2024; 15:1506073.

PMID: 39737183 PMC: 11682977. DOI: 10.3389/fimmu.2024.1506073.

The Inflammation-Induced Dysregulation of Reelin Homeostasis Hypothesis of Alzheimer's Disease.

Reive B, Lau V, Sanchez-Lafuente C, Henri-Bhargava A, Kalynchuk L, Tremblay M J Alzheimers Dis. 2024; 100(4):1099-1119.

PMID: 38995785 PMC: 11380287. DOI: 10.3233/JAD-240088.

Emerging T cell immunoregulatory mechanisms in multiple sclerosis and Alzheimer's disease.

Hawiger D Front Aging Neurosci. 2024; 16:1350240.

PMID: 38435400 PMC: 10904586. DOI: 10.3389/fnagi.2024.1350240.

The Biochemistry Behind Cognitive Decline: Biomarkers of Alzheimer's Disease.

Grari O, Elmoujtahide D, Sebbar E, Choukri M EJIFCC. 2024; 34(4):276-283.

PMID: 38303754 PMC: 10828533.

References

Martorana A, Bulati M, Buffa S, Pellicano M, Caruso C, Candore G . Immunosenescence, inflammation and Alzheimer's disease. Longev Healthspan. 2014; 1:8. PMC: 3922958. DOI: 10.1186/2046-2395-1-8. View

Ghochikyan A, Mkrtichyan M, Petrushina I, Movsesyan N, Karapetyan A, Cribbs D . Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch. Vaccine. 2005; 24(13):2275-82. PMC: 2081151. DOI: 10.1016/j.vaccine.2005.11.039. View

McQuillan K, Lynch M, Mills K . Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells. Brain Behav Immun. 2010; 24(4):598-607. DOI: 10.1016/j.bbi.2010.01.003. View

Heneka M, Carson M, El Khoury J, Landreth G, Brosseron F, Feinstein D . Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015; 14(4):388-405. PMC: 5909703. DOI: 10.1016/S1474-4422(15)70016-5. View

Zotova E, Nicoll J, Kalaria R, Holmes C, Boche D . Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther. 2010; 2(1):1. PMC: 2874260. DOI: 10.1186/alzrt24. View

Baruch K, Rosenzweig N, Kertser A, Deczkowska A, Sharif A, Spinrad A . Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology. Nat Commun. 2015; 6:7967. PMC: 4557123. DOI: 10.1038/ncomms8967. View

Baruch K, Deczkowska A, David E, Castellano J, Miller O, Kertser A . Aging. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. 2014; 346(6205):89-93. PMC: 4869326. DOI: 10.1126/science.1252945. View

Mehlhorn G, Hollborn M, Schliebs R . Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int J Dev Neurosci. 2000; 18(4-5):423-31. DOI: 10.1016/s0736-5748(00)00012-5. View

Racke M, Boone L, Hepburn D, Parsadainian M, Bryan M, Ness D . Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta. J Neurosci. 2005; 25(3):629-36. PMC: 6725332. DOI: 10.1523/JNEUROSCI.4337-04.2005. View

10.

Baruch K, Ron-Harel N, Gal H, Deczkowska A, Shifrut E, Ndifon W . CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc Natl Acad Sci U S A. 2013; 110(6):2264-9. PMC: 3568380. DOI: 10.1073/pnas.1211270110. View

11.

DAgostino P, Gottfried-Blackmore A, Anandasabapathy N, Bulloch K . Brain dendritic cells: biology and pathology. Acta Neuropathol. 2012; 124(5):599-614. PMC: 3700359. DOI: 10.1007/s00401-012-1018-0. View

12.

Buckwalter M, Coleman B, Buttini M, Barbour R, Schenk D, Games D . Increased T cell recruitment to the CNS after amyloid beta 1-42 immunization in Alzheimer's mice overproducing transforming growth factor-beta 1. J Neurosci. 2006; 26(44):11437-41. PMC: 1892201. DOI: 10.1523/JNEUROSCI.2436-06.2006. View

13.

Bi F, Huang C, Tong J, Qiu G, Huang B, Wu Q . Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci U S A. 2013; 110(10):4069-74. PMC: 3593910. DOI: 10.1073/pnas.1218497110. View

14.

Streit W, Sammons N, Kuhns A, Sparks D . Dystrophic microglia in the aging human brain. Glia. 2004; 45(2):208-12. DOI: 10.1002/glia.10319. View

15.

Sharma V, Mishra M, Ghosh S, Tewari R, Basu A, Seth P . Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res Bull. 2007; 73(1-3):55-63. DOI: 10.1016/j.brainresbull.2007.01.016. View

16.

Spector R, Johanson C . Sustained choroid plexus function in human elderly and Alzheimer's disease patients. Fluids Barriers CNS. 2013; 10(1):28. PMC: 3849253. DOI: 10.1186/2045-8118-10-28. View

17.

Weiss R, Lifshitz V, Frenkel D . TGF-β1 affects endothelial cell interaction with macrophages and T cells leading to the development of cerebrovascular amyloidosis. Brain Behav Immun. 2010; 25(5):1017-24. DOI: 10.1016/j.bbi.2010.11.012. View

18.

Sheng J, Jones R, Zhou X, McGinness J, Van Eldik L, Mrak R . Interleukin-1 promotion of MAPK-p38 overexpression in experimental animals and in Alzheimer's disease: potential significance for tau protein phosphorylation. Neurochem Int. 2001; 39(5-6):341-8. PMC: 3833633. DOI: 10.1016/s0197-0186(01)00041-9. View

19.

Ciaramella A, Salani F, Bizzoni F, Orfei M, Langella R, Angelucci F . The stimulation of dendritic cells by amyloid beta 1-42 reduces BDNF production in Alzheimer's disease patients. Brain Behav Immun. 2013; 32:29-32. DOI: 10.1016/j.bbi.2013.04.001. View

20.

Monsonego A, Imitola J, Petrovic S, Zota V, Nemirovsky A, Baron R . Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2006; 103(13):5048-53. PMC: 1458792. DOI: 10.1073/pnas.0506209103. View